id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-N-0021-0009,FDA,FDA-2005-N-0021,"Letter to Symrise, Inc from FDA CDER",Other,Letter(s),2020-11-02T05:00:00Z,2020,11,2020-11-02T05:00:00Z,,2020-11-02T17:43:09Z,,0,0,09000064849469b9
FDA-2005-N-0021-0008,FDA,FDA-2005-N-0021,Climbazole TEA Letter to Representatives of Symrise Inc. and Proctor and Gamble,Other,Letter(s),2020-01-14T05:00:00Z,2020,1,2020-01-14T05:00:00Z,,2020-01-14T16:13:20Z,,0,0,09000064842a002e